<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01529372</url>
  </required_header>
  <id_info>
    <org_study_id>CLIN-0020-HT</org_study_id>
    <nct_id>NCT01529372</nct_id>
  </id_info>
  <brief_title>REnAL denervatIon by ultraSound Transcatheter Emission</brief_title>
  <acronym>REALISE</acronym>
  <official_title>REnAL denervatIon by ultraSound Transcatheter Emission</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ReCor Medical, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ReCor Medical, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The REALISE trial is a single-arm, open-label, prospective, post market evaluation to be
      conducted on twenty (20) eligible patients with a twelve month follow-up period.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">June 2016</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of successful interventions</measure>
    <time_frame>Up to 24 hours</time_frame>
    <description>A successful intervention is defined by the ability to successfully:
Introduce the PRDS catheter
Position the PRDS catheter
Deliver ultrasound energy
Retrieve the PRDS catheter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of patients with device- or procedure-related adverse events</measure>
    <time_frame>12 months</time_frame>
    <description>Anticipated adverse events include:
Puncture site-related events
Renal artery stenosis, aneurysm, dissection, or perforation
Renal infarction, acute kidney injury, or renal failure
Arterial and venous thromboembolic events (including myocardial infarction, stroke, aortic or peripheral artery disease, etc.)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in ambulatory blood pressure</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in anti-hypertensive medication intake</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Resistant Hypertension</condition>
  <arm_group>
    <arm_group_label>Percutaneous renal denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PARADISE percutaneous renal denervation</intervention_name>
    <description>Intravascular ultrasound emission</description>
    <arm_group_label>Percutaneous renal denervation</arm_group_label>
    <other_name>ReCor Medical PARADISE</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resistant hypertension, as defined in the 2007 ESH-ESC guidelines

          -  18 years of age or older

          -  Negative pregnancy test for female patients of childbearing potential

          -  Willing and able to comply with follow-up requirements

          -  Signed informed consent

        Exclusion Criteria:

          -  Secondary hypertension

          -  Main renal arteries length &lt; 20 mm

          -  Main renal arteries diameter &lt; 4 mm

          -  Renal artery stenosis

          -  Iliac/femoral artery stenosis precluding insertion of the catheter

          -  Allergy to contrast media

          -  Currently participating in the study of an investigational drug or device

          -  Hemodynamics abnormality

          -  Moderate to severe renal insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilles Montalescot, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Pitié-Salpêtrière</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Université de Toulouse et CHU</name>
      <address>
        <city>Toulouse</city>
        <zip>1048</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <state>Île-de-France</state>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2012</study_first_submitted>
  <study_first_submitted_qc>February 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2012</study_first_posted>
  <last_update_submitted>April 4, 2016</last_update_submitted>
  <last_update_submitted_qc>April 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Renal denervation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

